probiotics glp 1 Pendulum Therapeutics Introduces GLP-1 Probiotic and chicory inulin GLP-Pro™: Probiotic & Postbiotic Blend

The existing evidence suggests a positive safety profile including a low risk of hypoglycaemia, convenience in usage, needing no dosage adjustment, and the ability to be taken at any time of the day, irrespective of meals

Bodies don't want to make their own hormones when receiving them externally

Patients with specific GLP1R variants may experience stronger appetite suppression and faster weight loss with semaglutide, while others with different genetic profiles show superior results with tirzepatide's dual-hormone mechanism

Table 2 gives an overview on the cardiovascular safety data of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, and sitagliptin

Dahl K, Brooks A, Almazedi F, Hoff ST, Boschini C, Baekdal TA